Physician profile
Janet I-Ping Lin
NPI 1477588358
$1,331.34
in general payments reported to CMS, 2019-2025
21 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $39.06 · 2021: $55.44 · 2022: $16.04 · 2023: $308 · 2024: $261 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $194.49 | 2019-2025 | |
| Lilly USA, LLC | $134.31 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Merck Sharp & Dohme LLC | $113.93 | 2019 | |
| Novo Nordisk INC | $112.12 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $105.34 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $89.92 | 2019-2025 | Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $83.44 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.20 | 2023-2025 | Jardiance |
| Abbott Laboratories | $73.69 | 2023-2025 | Freestyle Libre 3 |
| Abbvie INC. | $61.11 | 2019 | |
| Boston Scientific Corporation | $49.44 | 2023 | Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.07 | 2019 | |
| Sanofi-Aventis U.S. LLC | $32.95 | 2019 | |
| Exact Sciences Corporation | $30.66 | 2024-2025 | Cologuard Collection Kit |
| Echosens North America, INC. | $25.72 | 2023 | Fibroscan |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $24.18 | 2019 | |
| Amgen INC. | $22.26 | 2025 | Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $21.09 | 2024 | |
| Ge Healthcare | $16.88 | 2019 | |
| Amarin Pharma, INC. | $16.06 | 2019 | |
| Shire North American Group INC | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.